Home / Resources / News / PharmaVoice Talks to Suzanne Kincaid About the Clinical Research Industry’s Shift to Hybrid and Virtual Trials

The Aperio Blog

Home / Resources / News / PharmaVoice Talks to Suzanne Kincaid About the Clinical Research Industry’s Shift to Hybrid and Virtual Trials

PharmaVoice Talks to Suzanne Kincaid About the Clinical Research Industry’s Shift to Hybrid and Virtual Trials

September 10, 2020

Suzanne Kincaid – 2020 PharmaVOICE 100 winner – speaks with PharmaVOICE Editor Taren Grom about her passion for mentoring the next generation of clinical research professionals and her thoughts on the clinical research industry’s rapid shift towards hybrid and virtual trials.

About Aperio Clinical Outcomes

Aperio Clinical Outcomes provides full, customizable clinical research services across multiple therapeutic areas. Dedicated to transparent interactions with clients, Aperio also offers consulting services in Quality Assurance, Strategic Resourcing, and practical application of the latest Clinical Trial Technology.

In an industry flooded with data, metrics and technology, Aperio remains steadfastly focused on the most important part of the process: people. From start-up to close out and every point in between, Aperio works with its partners to deliver outcomes that will improve patient care and save lives.

Aperio Clinical Outcomes.
We make it clear.

Share this...

Learn how Aperio Clinical Outcomes can help you.
Contact us today.